Nutrien PT Raised to $67 at Berenberg
Berenberg analyst raised the price target on Nutrien (NTR) to $67.00 (from $49.00) while maintaining a Hold rating.
Neutral
or
Nutrien News & Analysis
-
-
Govt releases commemorative Rs 100 NTR coin
President Droupadi Murmu released a commemorative coin on legendary actor and former chief minister of unified Andhra Pradesh late N T Rama Rao on his centenary year at the Rashtrapati...
-
Barclays downgrades Nutrien to 'underweight' with a price target of $68.00
An analyst from Barclays downgraded Nutrien (NYSE: NTR) from 'overweight' to 'underweight' with a price target of $68.00 from a prior price target of %currency%%price%. Prior to this...
-
Stifel maintains Nutrien at 'buy' with a price target of $76.00
An analyst from Stifel maintained Nutrien (NYSE: NTR) at 'buy' with a price target of $76.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had 15 buy...
-
Piper Sandler maintains Nutrien at 'neutral' with a price target of $73.00
An analyst from Piper Sandler maintained Nutrien (NYSE: NTR) at 'neutral' with a price target of $73.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had...
-
Mizuho Securities maintains Nutrien at 'neutral' with a price target of $73.00
An analyst from Mizuho Securities maintained Nutrien (NYSE: NTR) at 'neutral' with a price target of $73.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien...
-
Nutrien Declares $0.53 Quarterly Dividend; 3.1% Yield
Nutrien (NYSE:NTR) declared a quarterly dividend of $0.53 per share, or $2.12 annualized.The dividend will be payable on October 13, 2023, to stockholders of record on September 29,...
-
Nutrien earnings missed by $0.30, revenue topped estimates
Investing.com - Nutrien (NYSE: NTR) reported second quarter EPS of $2.53, $0.30 worse than the analyst estimate of $2.83. Revenue for the quarter came in at $11.65B versus the consensus...
-
4 big analyst picks: Sweetgreen surges on upgrade, Nutrien raised to buy
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: Upgrades at |Sweetgreen, Nutrien, Bath & Body Works, and Verra Mobility.InvestingPro subscribers...
-
TD Securities upgrades Nutrien to 'buy' with a price target of $83.00
An analyst from TD Securities upgraded Nutrien (NYSE: NTR) from 'hold' to 'buy' with a price target of $83.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien...
-
Mizuho Securities maintains Nutrien at 'neutral' with a price target of $74.00
An analyst from Mizuho Securities maintained Nutrien (NYSE: NTR) at 'neutral' with a price target of $74.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien...
-
Wells Fargo maintains Nutrien at 'overweight' with a price target of $882.00
An analyst from Wells Fargo maintained Nutrien (NYSE: NTR) at 'overweight' with a price target of $882.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien...
-
UBS maintains Nutrien at 'buy' with a price target of $80.00
An analyst from UBS maintained Nutrien (NYSE: NTR) at 'buy' with a price target of $80.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had 14 buy...
-
Nutrien Announces Potash Production Curtailments Due to Port of Vancouver Strike
Nutrien Ltd. (NTR) announced today that it has curtailed production at its Cory potash mine due to the loss of export capacity through Canpotex’s Neptune terminal as a result of the...
-
Raymond James maintains Nutrien at 'outperform' with a price target of $80.00
An analyst from Raymond James maintained Nutrien (NYSE: NTR) at 'outperform' with a price target of $80.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien...
-
BofA Securities maintains Nutrien at 'buy' with a price target of $85.00
An analyst from BofA Securities maintained Nutrien (NYSE: NTR) at 'buy' with a price target of $85.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had...
-
Morgan Stanley maintains Nutrien at 'equalweight' with a price target of $70.00
An analyst from Morgan Stanley maintained Nutrien (NYSE: NTR) at 'equalweight' with a price target of $70.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien...
-
JPMorgan maintains Nutrien at 'overweight' with a price target of $78.00
An analyst from JPMorgan maintained Nutrien (NYSE: NTR) at 'overweight' with a price target of $78.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had 14...
-
Piper Sandler maintains Nutrien at 'neutral' with a price target of $70.00
An analyst from Piper Sandler maintained Nutrien (NYSE: NTR) at 'neutral' with a price target of $70.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had...
-
Berenberg downgrades Nutrien to 'hold' with a price target of $49.00
An analyst from Berenberg downgraded Nutrien (NYSE: NTR) from 'buy' to 'hold' with a price target of $49.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien...
-
Bunge Limited , Nutrien Ag Solutions Announce Strategic Alliance to Enhance Support to U.S. Farmers in the Transition to Lower-Carbon Agriculture
Bunge (NYSE:BG) and Nutrien (NYSE:NTR) Ag Solutions, the retail division of Nutrien Ltd. (TSX and NYSE: NTR), announced today a strategic alliance and commercial agreement to support...
-
BMO Capital maintains Nutrien at 'outperform' with a price target of $90.00
An analyst from BMO Capital maintained Nutrien (NYSE: NTR) at 'outperform' with a price target of $90.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had...
-
PointState Capital enters Coupang , Kinross Gold , Meta (META), Vertiv , more - 13F
PointState Capital LP released its 13F for the quarter ended March 31, 2023. Below is a summary:New Stakes CENTENE CORPORATION (CNC) new 628,604 share position Coupang (CPNG) new 5,017,965...
-
Wells Fargo maintains Nutrien at 'equal weight' with a price target of $62.00
An analyst from Wells Fargo maintained Nutrien (NYSE: NTR) at 'equal weight' with a price target of $62.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had...
-
Nutrien at an 'attractive entry point,' farmer demand re-emerging, says Raymond James
Raymond James upgraded to Nutrien (NYSE:NTR) to Outperform from Market Perform with an $85 per share price target in a note Friday. On Wednesday, Nutrien reported {{erl-1057243||earnings...
-
TD Securities maintains Nutrien at 'hold' with a price target of $72.00
An analyst from TD Securities maintained Nutrien (NYSE: NTR) at 'hold' and a price target of $72.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had 14 buy...
-
Barclays maintains Nutrien at 'overweight' with a price target of $80.00
An analyst from Barclays maintained Nutrien (NYSE: NTR) at 'overweight' and a price target of $80.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had 14...
-
UBS maintains Nutrien at 'buy' with a price target of $91.00
An analyst from UBS maintained Nutrien (NYSE: NTR) at 'buy' and a price target of $91.00 from a prior price target of %currency%%price%. Prior to this rating, Nutrien had 14 buy ratings, 9...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
